Clinical Trial Update: Synergistic Minimally Invasive Surgery and Deferoxamine in ICH [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating synergistic minimally invasive surgery with deferoxamine for intracerebral hemorrhage is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING